Egypt
Companies
US-based Bristol-Myers Squibb (BMS)'s decision to reduce its exposure to two of the most challenging emerging markets suggests that it has lost its appetite for risk. BMS has sold...
2008-10-16Companies
Egypt's unfavourable regulatory environment is forcing the Egyptian International Pharmaceutical Industries Company (EIPICO) to look abroad for growth, according to company chairman...
2008-06-13Industry
Middle Eastern investment bank Abraaj Capital has acquired a 76.9% stake in Egypt's largest medical testing company, Al Borg Laboratory, through a public tender offer. Al Borg operates...
2008-05-29Industry
Egypt's Ministry of Health and Population has bowed to pressure from manufacturers worried by rising raw material costs and agreed an 8% increase in the price of 265 drugs, representing...
2008-01-25Companies
Egypt's pharmaceutical market is dominated by cheap locally produced generics - 93% of local demand is met by domestic production in volume terms. However, this may be about to change...
2007-10-26Companies
Egypt's health minister Hatem El-Gabali is looking to continue his reform agenda in 2007, with plans to push forward with a universal health system that will provide basic healthcare...
2007-01-19Companies
Egypt's drug market was worth US$1.14bn in 2005 and is one of the largest in the Middle East and North Africa (MENA) region. However,
2007-01-18
